Current Pharmaceutical Design

William A. Banks  
Building 1, Room 810A
1600 S. Columbian Way
Seattle, WA 98108


Cyclooxygenases in the Central Nervous System: Implications for Treatment of Neurological Disorders

Author(s): A. Yermakova and M. K. O'Banion

Affiliation: Departments of Neurobiology&Anatomy and Neurology, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Box 603, Rochester,NY 14642, USA.


Recognition of two isoforms of cyclooxygenase and reports that nonsteroidal anti-inflammatory drugs may be beneficial in devastating neurological conditions such as Alzheimers disease have led to increased interest in cyclooxygenase function in the nervous system. In the present paper we review current data on the multiplicity of cyclooxygenase and prostaglandin mediated effects in the central nervous system (CNS). We discuss CNS cells types, including neurons, glia, and cerebrovascular elements, where cyclooxygenases-1 and -2 are expressed under normal conditions or can be induced by physiological or pathological stimuli. We also address physiological processes such as pain sensitization, CNS inflammation and fever induction that are regulated or modified by cyclooxygenase activity. Finally, we describe potential roles of cyclooxygenase in neurological diseases and rationales for nonsteroidal anti-inflammatory drug use in the treatment of neurodegenerative disorders, stroke and CNS injury.

Order Reprints Order Eprints Rights & PermissionsPrintExport

Article Details

Page: [1755 - 1776]
Pages: 22
DOI: 10.2174/1381612003398672
Price: $58